NRX Pharmaceuticals Inc (NRXP)

NRX Pharmaceuticals Inc (NRXP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $113M; returns 1 day +3.8%, 1 week -4.2%, 1 year -22.2%.

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for central nervous system (CNS) disorders, with a primary emphasis on suicidal depression, post-traumatic stress disorder (PTSD), and chronic pain. The company's business model is centered on its NMDA-receptor based drug pipeline.

Groups NRXP belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• CNS Disorders
• Mental Health Solutions
• Healthcare
• Pharmaceuticals
• Fast Track Designation
• Clinical Stage
• Neuroscience

NRXP financial model: income statement, cash flow and balance sheet